Joachim-Friedrich Kapp

SVP, Clinical Development, Autoimmunity at Aditx Therapeutics

Brings over 3 decades of experience with regulatory agencies such as the FDA and its European counterparts. Board-certified in Pharmacology & Toxicology, and Clinical Pharmacology. Former President Global Business Unit (GBU) Specialized Therapeutics at Schering AG.

Links

Org chart

View in org chart

Manager

Amro Albanna

Co-Founder & CEO

Peers

Corinne Pankovcin

Chief Commercialization Officer

Rowena Albanna

COO

Shahrokh Shabahang

Co-Founder, Chief Innovation Officer & Board Member

Reports

Steve Varvel

Director Of Clinical Trials - Aditxtscore

Rochelle Renkar

Pre-analytics And Phlebotomy Services Manager

View in org chart

Teams

CEO and Executive Team

6 members

Leadership Team

8 members

Timeline

SVP, Clinical Development, Autoimmunity
Current role

A panel showing how The Org can help with contacting the right person.